BioVeritas
Biotechnology ResearchTexas, United States51-200 Employees
BioVeritas is redefining the future of SAF by unlocking more feedstocks and using less energy to deliver superior carbon intensity.
Sustainable Innovation BioVeritas focuses on developing advanced sustainable aviation fuel (SAF) processes, emphasizing environmental impact reduction and energy efficiency, which may open opportunities for partners specializing in green technologies and environmental certifications.
Rapid Market Expansion Recent facility expansions and leadership hires indicate a strong growth trajectory and increased capacity for SAF production, suggesting a need for supply chain and equipment suppliers, as well as potential collaboration on scaling operations.
Technological Advancement Utilization of cutting-edge technology such as proprietary upcycling processes and process development indicates a readiness to adopt innovative solutions—ideal for companies providing process optimization, engineering, or materials innovations.
Financial Robustness With a revenue range of up to $250 million and significant funding of $65 million, BioVeritas has the financial capability to invest in new technologies, strategic partnerships, and joint ventures, presenting opportunities for investors and technology providers.
Market Positioning BioVeritas's active engagement in industry summits and leadership in SAF process launches position it as a key player in the renewable fuels sector, making it a strategic partner for companies aiming to enter or expand within the sustainable fuels market.
BioVeritas uses 8 technology products and services including MySQL, Webpack, Sentry, and more. Explore BioVeritas's tech stack below.
| BioVeritas Email Formats | Percentage |
| FLast@bioveritas.com | 50% |
| FLast@bioveritas.com | 50% |
Biotechnology ResearchTexas, United States51-200 Employees
BioVeritas is redefining the future of SAF by unlocking more feedstocks and using less energy to deliver superior carbon intensity.
BioVeritas has raised a total of $65M of funding over 1 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $65M.
BioVeritas's revenue is estimated to be in the range of $100M$250M
BioVeritas has raised a total of $65M of funding over 1 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $65M.
BioVeritas's revenue is estimated to be in the range of $100M$250M